Home
Groups
Pages
Marketplace
See More
Groups Pages Marketplace Events Blogs Funding Offers Courses
Sign In Sign Up
Night Mode
Trastuzumab Botidotin: Ushering HER2-Targeted Therapy into a New Era of Dual-Epitope Synergy
As precision oncology continues to advance, HER2 (human epidermal growth factor receptor 2) has become one of the most mature and clinically valuable therapeutic targets across multiple solid tumors. With an improved understanding of tumor heterogeneity and mechanisms of drug resistance, the limitations of single-target, single-mechanism treatment strategies have become increasingly evident....
0 Comments ·0 Shares ·182 Views ·0 Reviews
Please log in to like, share and comment!